zarontin

Generic: ethosuximide

Labeler: parke-davis div of pfizer inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name zarontin
Generic Name ethosuximide
Labeler parke-davis div of pfizer inc
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

ethosuximide 250 mg/5mL

Manufacturer
Parke-Davis Div of Pfizer Inc

Identifiers & Regulatory

Product NDC 0071-2418
Product ID 0071-2418_6afa95d3-162a-4fbb-ab47-561f4ee7771a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA080258
Listing Expiration 2026-12-31
Marketing Start 2020-03-10

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00712418
Hyphenated Format 0071-2418

Supplemental Identifiers

RxCUI
251322 755357
UNII
5SEH9X1D1D
NUI
N0000175753 N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zarontin (source: ndc)
Generic Name ethosuximide (source: ndc)
Application Number ANDA080258 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/5mL
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (0071-2418-19) / 474 mL in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

0071-2418-19 1 BOTTLE, PLASTIC in 1 CARTON (0071-2418-19) / 474 mL in 1 BOTTLE, PLASTIC

Ingredients (1)

ethosuximide (250 mg/5mL)

Linked Drug Pages (1)

Zarontin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "6afa95d3-162a-4fbb-ab47-561f4ee7771a", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["5SEH9X1D1D"], "rxcui": ["251322", "755357"], "spl_set_id": ["7bf3e616-45e8-4469-a75d-4d824ce951ea"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (0071-2418-19)  / 474 mL in 1 BOTTLE, PLASTIC", "package_ndc": "0071-2418-19", "marketing_start_date": "20220601"}], "brand_name": "Zarontin", "product_id": "0071-2418_6afa95d3-162a-4fbb-ab47-561f4ee7771a", "dosage_form": "SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0071-2418", "generic_name": "Ethosuximide", "labeler_name": "Parke-Davis Div of Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zarontin", "active_ingredients": [{"name": "ETHOSUXIMIDE", "strength": "250 mg/5mL"}], "application_number": "ANDA080258", "marketing_category": "ANDA", "marketing_start_date": "20200310", "listing_expiration_date": "20261231"}